BCLI 8-K 2026-07-30

BRAINSTORM CELL THERAPEUTICS INC. (BCLI) 8-K dated 2026-07-30 — accession 0001104659-26-088728.

BRAINSTORM CELL THERAPEUTICS INC. (BCLI) is a biotechnology company listed on US.

BRAINSTORM CELL THERAPEUTICS INC. filed a 8-K on 2026-07-30. Accession 0001104659-26-088728.

This 8-K covers: Director/officer change (Item 5.02), Reg FD disclosure (Item 7.01), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Income-statement cache for BCLI is thin on this filing URL. We will not invent exhibit numbers.

Not investment advice. The BCLI SEC hub lists recent forms. The stock page is the research view.